ISDA

Deposition Date 2006-08-22

Release Date 2006-10-24

Last Version Date 2024-10-30

Entry Detail

PDB ID:

2I4Q

Keywords:

HYDROLASE

Title:

Human renin/PF02342674 complex

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.26

R-Value Work:

0.22

R-Value Observed:

0.23

Space Group:

P 21 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Renin
Gene (Uniprot):REN
Chain IDs:A, B
Chain Length:336
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P00797 Pfam ID:PF00026 EC:3.4.23.15

Ligand Molecules

UA4

Primary Citation

Rational design of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as small molecule renin inhibitors.

Powell, N.A, Ciske, F.L, Cai, C, Holsworth, D.D, Mennen, K, Van Huis, C.A, Jalaie, M, Day, J, Mastronardi, M, McConnell, P, Mochalkin, I, Zhang, E, Ryan, M.J, Bryant, J, Collard, W, Ferreira, S, Gu, C, Collins, R, Edmunds, J.J.Show

Bioorg.Med.Chem. 15 5912 5949 (2007)

PMID: 17574423 DOI: 10.1016/j.bmc.2007.05.069

Abstact

We report the design and synthesis of a series of 6-(2,4-diaminopyrimidinyl)-1,4-benzoxazin-3-ones as orally bioavailable small molecule inhibitors of renin. Compounds with a 2-methyl-2-aryl substitution pattern exhibit potent renin inhibition and good permeability, solubility, and metabolic stability. Oral bioavailability was found to be dependent on metabolic clearance and cellular permeability, and was optimized through modulation of the sidechain that binds in the S3(sp) subsite.

Legend

Protein

Chemical

Disease

Primary Citation of related structures